MedCognetics, Inc. announced it has received U.S. Food and Drug Administration 510(k) clearance for CogNet AI-MT+, its enhanced AI-enabled radiological computer-aided triage and notification software. The device is cleared under 21 CFR 892.2080 for Radiological Computer Aided Triage and Notification Software, with the FDA determining it to be substantially equivalent to legally marketed predicate devices, permitting commercialization in the United States. This clearance expands MedCognetics' regulatory footprint in AI-driven breast imaging.
CogNet AI-MT+ integrates into existing imaging systems to help radiologists manage increasing imaging volumes by flagging suspicious 3D mammography exams for prioritized review. The software employs advanced AI and Machine Learning to detect early signs of cancer across all ethnicities, reflecting the company's mission to improve health equity through unbiased AI. The platform is trained on a diverse global dataset to mitigate data bias, advancing the performance of radiologists and imaging centers while delivering accurate care for patients worldwide.
This development represents a significant step in addressing workflow challenges in radiology departments facing growing imaging demands. By automatically triaging mammogram images and identifying those requiring urgent attention, the technology could potentially reduce delays in diagnosis and treatment. The FDA clearance under Product Code QFM, Class II classification validates the software's safety and effectiveness for its intended use in clinical settings.
MedCognetics provides an advanced AI software platform that integrates into radiology workflow, with the company positioned at the forefront of creating more predictable medical outcomes through unbiased AI services. The CogNet AI-MT+ is part of MedCognetics' comprehensive CogNet AI platform designed to enhance radiologists' capabilities by expanding insights and awareness in medical imaging. For more information about the company and its technologies, visit https://www.medcognetics.com.
